These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
903 related articles for article (PubMed ID: 32767026)
1. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells. Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026 [TBL] [Abstract][Full Text] [Related]
2. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
3. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC. Chen C; Zhang M; Zhang Y Cell Transplant; 2020; 29():963689720961070. PubMed ID: 32951448 [TBL] [Abstract][Full Text] [Related]
4. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis. Liu Y; Zhai R; Hu S; Liu J Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608 [TBL] [Abstract][Full Text] [Related]
6. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948 [TBL] [Abstract][Full Text] [Related]
7. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis. Shao N; Song L; Sun X Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734 [TBL] [Abstract][Full Text] [Related]
8. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement. Chen H; Li F; Xue Q Bioengineered; 2022 Feb; 13(2):2828-2840. PubMed ID: 35068326 [TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer. Chang F; Li J; Sun Q; Wei S; Song Y Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma. Cheng J; Zhang R; Yan M; Li Y BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer. Pang J; Ye L; Zhao D; Zhao D; Chen Q Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p. Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0085131 is involved in cisplatin-resistance of non-small-cell lung cancer cells by regulating autophagy. Kong R Cell Biol Int; 2020 Sep; 44(9):1945-1956. PubMed ID: 32449799 [TBL] [Abstract][Full Text] [Related]
14. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. Chu D; Li P; Li Y; Shi J; Huang S; Jiao P Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261 [TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway. Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091 [TBL] [Abstract][Full Text] [Related]
16. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression. Ju ZS; Sun B; Bao D; Zhang XF Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788 [TBL] [Abstract][Full Text] [Related]
17. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer. Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347 [TBL] [Abstract][Full Text] [Related]
18. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis. Wei D; Sun L; Feng W Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595 [TBL] [Abstract][Full Text] [Related]
19. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis. Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592 [TBL] [Abstract][Full Text] [Related]
20. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis. Hao D; Li Y; Shi J; Jiang J Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]